Invesco’s $652B Q4 Filing: The Broadest Book on the Street Joined the NFLX Accumulation Wave

Invesco Ltd. filed its Q4 2025 13F reporting $652 billion across 23,487 positions — up from $635B and 24,715 holdings in Q3. The numbers alone make Invesco one of the largest diversified asset managers on the street. But what’s striking isn’t the breadth — it’s that even a 23,000-line book couldn’t resist the same gravitational pull that moved Citadel, Goldman Sachs, and other mega-filers toward Netflix (NFLX) accumulation in Q4.

TL;DR

• AUM: $652B, up 2.7% from $635B in Q3 2025 — record quarter for Invesco
• Holdings: 23,487 positions (down from 24,715 in Q3 — 1,228 lines consolidated)
• Top Holding: NVDA at $26.7B (4.1%), essentially flat from Q3
• NFLX Surge: +836% shares (4.6M → 43.5M), value from $5.6B to $4.1B (price decline absorbed)
• New ISRG Position: Intuitive Surgical (ISRG) entered at $2.3B — entirely new
• NOW Build: ServiceNow (NOW) shares up 326% (1.3M → 5.6M), value from $1.2B to $856M
• Top-5 Concentration: 17.7% — one of the lowest among $500B+ managers
• Turnover: 52 new positions, 52 exits — low churn for a book this size

Filing Snapshot

Metric	Q3 2025	Q4 2025	Change
Total AUM	$634.7B	$652.2B	+2.7%
Holdings Count	24,715	23,487	-1,228
New Positions	—	52	—
Exited Positions	—	52	—
Top-5 Weight	~18.9%	17.7%	-1.2 pp
Filing Date	February 19, 2026 (report date: December 31, 2025)

Invesco Joined the NFLX Mega-Accumulation Wave

The pattern is unmistakable. In Q3 2025, Invesco held 4.6 million Netflix shares worth $5.6B. In Q4, that jumped to 43.5 million shares — an 836% increase. The dollar value actually fell to $4.1B because Netflix’s share price declined during the quarter, but the share-count move is the signal that matters.

This isn’t an Invesco-specific thesis. Citadel ramped NFLX 1,598% the same quarter. JPMorgan and other mega-filers showed similar builds. When a diversified asset manager with 23,000 positions converges on the same accumulation pattern as a multi-strategy hedge fund, it typically signals structural index or ETF rebalancing flows rather than independent stock-picking conviction.

Intuitive Surgical: A Brand-New $2.3B Position

Intuitive Surgical (ISRG) did not appear in Invesco’s Q3 13F. In Q4, it showed up at $2.3B across 4.1 million shares — the largest entirely new position in the filing. At 0.36% of AUM, it’s not a top-10 name, but a $2.3B initial entry in a single quarter is significant. ISRG’s dominance in robotic surgery (85%+ market share in the da Vinci platform) makes it a natural fit for Invesco’s growth-oriented sub-funds and health-care sector ETFs.

ServiceNow: The Quiet 326% Build

Beneath the NFLX and ISRG headlines, ServiceNow shares increased 326% — from 1.3 million to 5.6 million. The dollar value actually decreased from $1.2B to $856M, meaning Invesco was buying aggressively into price weakness. Again, this mirrors the pattern seen at Citadel (where NOW shares jumped 535%) and suggests cross-manager structural flows in enterprise SaaS names.

Top-5: Diversified by Design

Invesco’s top-5 concentration at 17.7% is remarkably low for a $652B book. Compare that to Citadel at 26.3% or Vanguard at significantly higher levels. The low concentration reflects Invesco’s business model: it runs hundreds of distinct fund vehicles — active, passive, factor-based, and thematic — each with different mandates. The 13F aggregates all of them.

Rank	Holding	Value	Weight	QoQ
1	NVDA	$26.7B	4.1%	+0.3% value
2	MSFT	$21.9B	3.4%	-6.8% value
3	AAPL	$20.0B	3.1%	+6.7% value
4	GOOGL	$14.2B	2.2%	Held
5	AMZN	$13.8B	2.1%	Held

No ETFs in the top-5 — this is pure equity. The top positions read like a market-cap-weighted index, which is exactly what you’d expect when hundreds of sub-funds are rolled into one filing.

Position Count: 1,228 Lines Consolidated

Invesco went from 24,715 to 23,487 positions — a drop of 1,228 lines. But with only 52 exits, most of the reduction came from line consolidation (merging share classes or de-duplication) rather than actual position liquidation. This is common for multi-fund managers whose sub-advisors may hold the same security across different mandates.

What This Filing Tells You About Q4 Market Structure

When you see the same names — NFLX, NOW, ISRG — showing up as major builds across managers with completely different strategies (multi-strategy hedge fund, diversified asset manager, investment bank), the signal is structural. Q4 2025 likely saw index reconstitution, ETF creation/redemption flows, or derivatives-driven inventory changes that pushed these names into multiple books simultaneously.

For retail investors tracking smart money, the takeaway isn’t “Invesco loves Netflix.” It’s that the entire institutional ecosystem rotated into these names for mechanical reasons. The question for Q1 2026 is whether those positions stick or unwind.

Frequently Asked Questions

Why does Invesco have so many more holdings than other $650B+ managers?

Invesco operates hundreds of distinct fund products — active mutual funds, factor ETFs (like the QQQ Trust), thematic products, and separately managed accounts. The 13F aggregates all of them into a single filing, producing a 23,000+ line item count that reflects business diversity, not individual portfolio complexity.

Is Invesco’s NFLX accumulation a bullish signal?

Not necessarily as a standalone signal. The 836% share increase mirrors the same pattern at Citadel (+1,598%) and other large filers. When multiple managers with different mandates build the same name simultaneously, it usually indicates structural flows (index changes, ETF rebalancing) rather than independent conviction.

Why did Invesco add ISRG as a new $2.3B position?

Intuitive Surgical is a high-growth healthcare name that fits multiple Invesco fund mandates — growth, healthcare sector, and quality factor. A $2.3B initial build likely represents allocation across several sub-funds rather than a single concentrated bet.

How does Invesco’s 17.7% top-5 concentration compare to peers?

It’s among the lowest for $500B+ managers. Citadel runs at 26.3%, and most large index-heavy filers run higher. Invesco’s low concentration is a function of its multi-product business model, not a deliberate diversification strategy at the individual fund level.